COHERUS ONCOLOGY INC (CHRS) Stock Income Statement
NASDAQ:CHRS - Nasdaq - US19249H1032 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 197.50M | 266.96M | 257.24M | 211.00M | 326.60M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 85.62M | 117.55M | 158.99M | 70.10M | 57.60M | |||
| Gross Profit | 111.88M | 149.41M | 98.25M | 141.00M | 269.00M | |||
| Operating Expenses | 219.75M | 247.57M | 296.55M | 397.80M | 532.80M | |||
| Research and Development | 89.22M | 93.34M | 105.84M | 199.40M | 363.10M | |||
| Selling, General, and Administrative Expenses | 130.53M | 154.24M | 190.72M | 198.50M | 169.70M | |||
| Operating Income | -107.88M | -98.17M | -198.30M | -256.90M | -263.90M | |||
| Interest Income/Expense | -18.19M | -22.76M | -40.54M | -32.50M | -23.00M | |||
| Other Income/Expense | 691.00K | -1.03M | 5.47M | 3.80M | -300.00K | |||
| Non Recurring Items | N/A | 150.46M | -4.90M | -6.20M | N/A | |||
| Income Before Taxes | -121.77M | 28.51M | -238.27M | -291.80M | -287.10M | |||
| Income Tax | 0.00 | 0.00 | -380.00K | 0.00 | 0.00 | |||
| Net Income | -130.94M | 28.51M | -237.89M | -291.80M | -287.10M | |||
| EBITDA | -103.06M | -92.89M | -194.51M | -253.20M | -260.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.13 | 0.25 | -2.53 | -3.76 | -3.81 | |||
| Non GAAP EPS | -0.78 | -0.75 | -2.02 | -3.03 | -1.15 | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.65% | 55.97% | 38.19% | 66.82% | 82.36% | |||
| Profit Margin | -66.30% | 10.68% | -92.48% | -138.29% | -87.91% | |||
| Operating Profit Margin | -54.62% | -36.77% | -77.09% | -121.75% | -80.80% | |||
All data in USD